Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACAT: Ticagrelor vs Clopidogrel in Post-Fibrinolysis PCI
NCT02048085Phase 4Withdrawn
- Sponsor
- South Arkansas Regional Hospital
- Start
- Jan 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in acute ST-segment elevation myocardial infarction (STEMI), acute coronary syndrome (ACS), sponsored by South Arkansas Regional Hospital. Planned start Jan 2014; status: withdrawn.
02
Drugs
ticagrelor
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02048085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048085.